Form 8K Celularity Inc For: 29 July
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Celularity Inc (CELU)
Celularity Inc stock price live, this page displays NASDAQ CELU stock exchange data. View the CELU premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Celularity Inc real time stock price chart below.
What Is the Celularity Inc Stock Price Today?
The Celularity Inc stock price today is 3.120.
What Is the Stock Symbol for Celularity Inc?
The stock symbol for Celularity Inc is ""CELU.""
What Stock Exchange Does Celularity Inc Trade On?
Celularity Inc is listed and trades on the NASDAQ stock exchange.
Is Celularity Inc a Good Stock to Buy?
Determining whether Celularity Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CELU quote. (ISIN: US1511902041)
What Is the Celularity Inc Stock Price Today?
The Celularity Inc stock price today is 3.120.
What Is the Stock Symbol for Celularity Inc?
The stock symbol for Celularity Inc is ""CELU.""
What Stock Exchange Does Celularity Inc Trade On?
Celularity Inc is listed and trades on the NASDAQ stock exchange.
Is Celularity Inc a Good Stock to Buy?
Determining whether Celularity Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CELU quote. (ISIN: US1511902041)
NASDAQ
Currency in USD
3.120
-0.160(-4.88%)
Closed·
After Hours
3.160+0.040(+1.28%)
·
Fair Value
An estimate of a Celularity's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.100
3.300
52 wk Range
1.001
5.220
CELU Scorecard
Full Analysis
Operates with a significant debt burden
CELU is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Celularity's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.1003.300
52 wk Range
1.0015.220
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CELU Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Celularity's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to drop this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Celularity Inc Company Profile
Celularity Inc., a regenerative and cellular medicines company, focuses on addressing aging-related and degenerative diseases. It develops off-the-shelf placental-derived allogeneic cell therapy product candidates, including mesenchymal-like adherent stromal cells for diabetic foot ulcer and Crohn’s disease. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. Its therapeutic programs include PDA-001 for the treatment of autoimmune (Crohn’s) and degenerative disease; and PDA-002 for treating facioscapulohumeral muscular dystrophy. The company is also developing pExo-001, a human postpartum placenta derived exosome product for the treatment of osteoarthritis. In addition, it produces, sells, and licenses products used in surgical and wound care markets, such as Biovance, Biovance 3L, Rebound, Interfyl, and Centaflex; and collects, processes, and stores umbilical cord and placental blood and tissue after full-term pregnancies under the LifebankUSA brand. Celularity Inc. has licensing agreement with Sorrento Therapeutics, Inc. for the development and commercialization of licensed CD19 CAR-T products; and research collaboration services agreement with Regeneron Pharmaceuticals, Inc. to support the research of allogeneic cell therapy candidates. Celularity Inc. was founded in 1998 and is headquartered in Florham Park, New Jersey.
Compare CELU to Peers and Sector
Metrics to compare | CELU | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCELUPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.3x | −0.4x | −0.5x | |
PEG Ratio | −0.02 | −0.01 | 0.00 | |
Price/Book | 8.7x | 3.0x | 2.6x | |
Price / LTM Sales | 1.4x | 8.5x | 3.3x | |
Upside (Analyst Target) | - | 278.8% | 45.4% | |
Fair Value Upside | Unlock | 33.9% | 7.7% | Unlock |
Earnings
Latest Release
May 08, 2025
EPS / Forecast
-0.60 / -0.15
Revenue / Forecast
18.13M / --
People Also Watch
FAQ
What Stock Exchange Does Celularity Trade On?
Celularity is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Celularity?
The stock symbol for Celularity is "CELU."
What Is the Celularity Market Cap?
As of today, Celularity market cap is 77.03M.
What Is Celularity's Earnings Per Share (TTM)?
The Celularity EPS (TTM) is -2.64.
From a Technical Analysis Perspective, Is CELU a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Celularity Stock Split?
Celularity has split 1 times.
How Many Employees Does Celularity Have?
Celularity has 123 employees.
What is the current trading status of Celularity (CELU)?
As of 03 Aug 2025, Celularity (CELU) is trading at a price of 3.12, with a previous close of 3.28. The stock has fluctuated within a day range of 3.10 to 3.30, while its 52-week range spans from 1.00 to 5.22.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.